Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population
Susan Colilla(Bristol-Myers Squibb (United States)), Xianchen Liu(Shandong University), Daniel E. Singer(Harvard University), William Petkun(Bristol-Myers Squibb (United States)), Ann Crow(Bristol-Myers Squibb (United States)), Teresa A. Simon(Bristol-Myers Squibb (Germany))
Cited by 1,321
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919